Bone Graft Fixation System Market Insights, Facts, historical data and Statistics 2022-2032

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1381

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Bone Graft Fixation System market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Bone Graft Fixation System market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Bone Graft Fixation System Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Bone Graft Fixation System market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Bone Graft Fixation System market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Bone Graft Fixation System market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Discounted prices for new customers! Offer expires soon!

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1381

Bone Graft Fixation System Market: Segmentation

Valuable information covered in the FMI’s Bone Graft Fixation System market report has been segregated into key segments and sub-segments.

By Product Type:

  • Unilateral
  • Hybrid
  • Circular
  • Others

By Material:

  • Allograft
  • Synthetic

By Application:

  • Joint Reconstruction
  • Craniomaxillofacial
  • Foot & Ankle
  • Dental
  • Spinal Fusion

End User:

  • Hospitals
  • Specialty Clinics
  • Others

Bone Graft Fixation System Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Bone Graft Fixation System market. Competitive information detailed in the Bone Graft Fixation System market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Bone Graft Fixation System market report.

Key players covered in the report include:

  • DePuy Synthesis, Inc
  • Smith & Nephew
  • Auxein Medical
  • Stryker Corporation
  • Baumer S.A.
  • Mikai S.p.A
  • Biocomposites
  • Zimed Medikal
  • Zimmer Biomet
  • Acumed
  • Medtronic
  • Orthofix Holdings, Inc
  • Nuvasive, Inc.
  • Allograft Bone Chips

Important Questions Answered in the Bone Graft Fixation System Market Report

  • Which end user remains the top revenue contributor in different regional markets?
  • At what rate has the global Bone Graft Fixation System market been expanding during the forecast period?
  • How will the global Bone Graft Fixation System market look like by the end of the forecast period?
  • What innovative strategies are adopted by Bone Graft Fixation System market players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Bone Graft Fixation System market?

Buy Now@ https://www.futuremarketinsights.com/checkout/1381

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
  • Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
  • Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Bone Graft Fixation System market

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Small Animal Imaging (In Vivo) Market Trends: Development is Changing Business Needs

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

To Get the Sample Copy of Report visit@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1334

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Small Animal Imaging (In Vivo) market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Small Animal Imaging (In Vivo) market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Small Animal Imaging (In Vivo) Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Small Animal Imaging (In Vivo) market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Small Animal Imaging (In Vivo) market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Small Animal Imaging (In Vivo) market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Discounted prices for new customers! Offer expires soon!

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1334

Small Animal Imaging (In Vivo) Market: Segmentation

Valuable information covered in the FMI’s Small Animal Imaging (In Vivo) market report has been segregated into key segments and sub-segments.

By Application

  • Monitoring Drug Treatment Response
  • Bio Distribution Studies
  • Cancer Cell Detection
  • Biomarkers
  • Longitudinal Studies
  • Epigenetics

 By Technology

  • Micro-Magnetic Resonance Imaging (Micro-MRI)
  • Digital Angiography
  • Ultrasound
  • Nuclear Imaging
  • Micro-Positron Emission Tomography (Micro-PET)
  • Micro-Single Photon Emission Computerized Tomography (Micro-SPECT)
  • Optical Imaging (OI)
  • Bioluminescence Imaging
  • Cerenkov Luminescence Imaging
  • Others
  • Micro-Ultrasound Imaging
  • Micro-Computerized Tomography (Micro-CT)

 Small Animal Imaging (In Vivo) Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Small Animal Imaging (In Vivo) market.Competitive information detailed in the Small Animal Imaging (In Vivo) market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Small Animal Imaging (In Vivo) market report.

Key players covered in the report include:

  • Berthold Technologies,
  • Spectral Instruments Imaging,
  • Agilent Technologies, Inc.,
  • Aspect Imaging,
  • Bioscan, Inc.,
  • Bruker Corporation,
  • Gamma Medica-Ideas, Inc.,
  • Genovis Ab, Li-Cor Biosciences,
  • Life Technologies Corporation,
  •  Mediso Medical Imaging Systems,
  • Miltenyi Biotec Gmbh,
  •  Perkinelmer, Inc.,
  • Promega Corporation,
  • Scanco Medical Ag,
  • Siemens Ag,
  • Sofie Biosciences, Inc.,
  • Targeson, Inc.,
  • Uvp. LLC,
  • Fujifilm Holdings Corporation,
  • Thermo Fischer Scientific.

Request to View TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1334

Important Questions Answered in the Small Animal Imaging (In Vivo) Market Report

  • Which end user remains the top revenue contributor in different regional markets?
  • At what rate has the global Small Animal Imaging (In Vivo) market been expanding during the forecast period?
  • How will the global Small Animal Imaging (In Vivo) market look like by the end of the forecast period?
  • What innovative strategies are adopted by Small Animal Imaging (In Vivo) market players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Small Animal Imaging (In Vivo) market?

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
  • Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
  • Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Small Animal Imaging (In Vivo) market

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

3D Printed Medical Devices Market Size is set to Grow at a Remarkable Pace in the Coming Years

Global 3D Printed Medical Devices Market is set to experience a significant growth rate of 16.1% CAGR from 2022 to 2028, with an estimated market value of around US$ 752.5 Mn in 2022. As per Future Market Insights’ projections, plastic materials hold a substantial share of over 69.0% in 2021 within the global market.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Currently heading towards a market value of over US$ 440 Mn, the global 3D Printed Medical Devices Market is projected for stupendous growth at 16.1% CAGR during 2022- 2028. North America will remain the leading market for 3D Printed Medical Device sales, whereas the market attractiveness of Asia Pacific has been rising notably.

Data Points Market Insights
Market Value 2021 US$  637.1 Mn
Market Value 2028 US$  1,839.2 Mn
CAGR 2022-2028 16.1%
Market Share of Top 5 Countries 73.1%

 

The market growth is primarily assisted by advancements in 3D printing technology, surging government spending in healthcare sector, increasing usage of 3D printed medical devices for medical procedures, and relative simplification of the manufacturing process of 3D printed medical devices. Introduction of Computer-aided Design (CAD) for 3D printing can create trail ready devices, thereby reducing manufacturing time, time to market as well as operational cost.

Key Takeaways – 3D Printed Medical Devices Market Study

  • Although metals and alloys are most preferably used for 3D printed medical devices, biomaterial inks are expected to gain traction during the forecast period owing to their highly biocompatible and versatile physical properties.
  • PolyJet – InkJet 3D printing technology currently holds maximum share of 3D printed medical devices market. However, consistent development and adoption of innovative technologies may reduce the 3D printed medical devices market share of this technology during the forecast period.
  • Use of 3D printing technology in orthopedic implants is shaping the future of 3D printed medical devices market. It currently accounts for nearly half of the market value.
  • The consistently expanding patient pool and growing preference for personalized implants in joint replacement surgeries will remain key boosters to growth of 3D printed medical devices demand in orthopedics.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1501

Scope of the Report

Attribute Details
Forecast Period 2022-2028
Historical Data Available for 2014-2021
Market Analysis US$ Mn for Value
Key Regions Covered North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East & Africa
Key Countries Covered US, Canada,  Brazil,  Mexico, Germany, U.K., France, Italy, Spain, Nordic, Russia, Poland BENELUX, China, India, ASEAN, Australia, New Zealand, Japan, North Africa, GCC Countries, North Africa and South Africa
Key Market Segments Covered Technology,  Application, Material, Distribution Channel and Region
Key Companies Profiled
  • 3D Systems, Inc.
  • Arcam AB
  • Stratasys Ltd.
  • FabRx Ltd.
  • EOS GmbH Electro Optical Systems
  • EnvisionTEC
  • Cyfuse Biomedical K.K.
  • Bio3D Technologies

Who Is Winning?

Until late 2016, the key focus of most leading players in the 3D printed medical devices market was geographic expansion through acquisition and merger. In May 2016, Johnson & Johnson announced collaboration with a subsidiary of HP Inc. for manufacturing personalized healthcare solutions at reduced costs through 3D printing techniques. J&J collaborated with Organovo to carry out feasibility study on bio printed human tissue for testing new medications to work with Carbon 3D, famous for ultra-fast Continuous Liquid Interface Production (CLIP) technology for production of custom surgical devices.

The focuses is now gradually shifting towards expansion through strategic partnerships to improve their distribution network. For instance, in 2017, Envision partnered with ScanSource, Inc. to deliver 3D printing solutions to resellers in the Americas. Similarly, in 2018, 3D Systems and Stryker announced distribution partnership for VSP (Virtual Surgical Planning) and anatomical models for carniomaxillofacial specialty.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1501

Learn More about Report Inclusions

Future market insights offers a unique perspective and actionable insights on 3D printed medical devices market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022 – 2029 based on application (orthopedic implants, dental implants, carnio-maxillofacial Implant), material type (metals and alloys, biomaterial inks and plastics) technology (stereolithography (SLA) – liquid-based 3D printing, selective layer sintering (SLS) – powder-based 3d printing, digital light processing(DLP), fused deposition modelling (FDM)-plastic filament extrusion-based, polyjet – inkjet 3D printing, electronic beam melting (EBM) ) end user (hospitals, ambulatory surgical centers, diagnostic centers) in seven key regions.

Explore Other Reports Links from Healthcare Market

Advance Wound Care Market:- The Advance Wound Care Market is expected to witness phenomenal opportunities by exhibiting a stable CAGR of 3.7% during the forecast period between 2021 to 2031.

Metagenomics Market:- Widespread adoption of metagenomics tools in environmental monitoring and pollution reduction projects is estimated to boost the Metagenomics Market growth.

Dental Lasers Market:- Dental Lasers Market is likely to surpass a value of US$ 409 million in terms of revenue, indicating an increase of 1.4x in market growth rate, over the forecast period of 2022-2026.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

U.S. Compounding Pharmacies Market – Industry In-Depth Study and Huge Demand in Future 2022-2028

U.S. Compounding Pharmacies Market is projected to exceed US$ 4.64 Bn In 2022 and is expected to grow at over 5.1% CAGR between 2022 and 2028. Increasing focus on introducing innovative formulations to combat several diseases is driving the growth in the market.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-us-978

According to a recent research by Future Market Insights (FMI), the global compounding pharmacies market is estimated to have accounted around US$ 4.64 Bn in terms of value during 2022. The report on the U.S. Compounding Pharmacies Market also projects that the market will grow at a CAGR of approximately 5.1% during the period 2022-2028.

Attribute Details
U.S. Compounding Pharmacies Market Estimated Size in 2022 US$ 4.64 Bn
U.S. Compounding Pharmacies Market Projected Size in 2028 US$ 6.27 Bn
U.S. Compounding Pharmacies Market Historical CAGR (2013-2021) 5.8%  
U.S. Compounding Pharmacies Market Value-based CAGR (2022-2028) 5.1%  

The U.S. compounding pharmacies market revenue is expected to increase at a robust growth rate over the next few years despite the reporting of several adverse events and drug mismanagement-related deaths. The U.S. compounding pharmacies market is expected to gain popularity in several regions of the U.S. due to upcoming products and therapeutic areas that are yet to be tapped by branded manufacturers.

Focus on factors, such as the availability of drugs in innovative medium/forms and the administration of varying dosages for various indications, is expected to drive the adoption of newer dosage forms of compounded medications.

Market Remains Influenced by Availability of Compounded Pain Management Drugs

The growing popularity of pain management therapies is fuelling the growth of U.S. compounding pharmacies market. Compounded pain management drugs are not FDA-approved, however, they come under the State Pharmacies Board supervision in the U.S.

For example, medical guidelines such as the Chronic Pain Guidelines stated by the Medical Treatment Utilization Schedule (MTUS) do not support the use of compounds such as Gabapentin and Baclofen for pain management. However, compounding pharmacies use these compounds as well as several others in varying strengths to attract customers and increase their revenue.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-us-978

Scope of the Report

Attribute Details
Forecast Period 2022-2028
Historical Data Available for 2013-2021
Market Analysis US$ Bn for Value
Key Regions Covered North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market Segments Covered Product, Pharmacy Type, Application, and Sterility
Key Companies Profiled • Avella Specialty Pharmacy
• Central Admixture Pharmacy Services Inc.
• Hoye’s Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Cantrell Drug Company
• Clinigen Group, Dougherty’s Pharmacy
• Fagron N.V.

Moreover, an increase in the shortage of prescription medicine is expected to upsurge the demand for compounding pharmacies. According to the U.S. FDA, only 154 drugs were in short supply or not available in 2007, as compared to 456 in 2012.

Currently, the number of drugs in short supply is around 300. Medicinal drought is prominent in the U.S. as compared to other countries, which is also fuelling the revenue growth of the U.S. compounding pharmacies market.

On the other hand, increasing regulatory pressures are expected to hamper the growth of the U.S. compounding pharmacies market. Compounding pharmacies are engaged in trans-boundary drug compounding, and the manufacturing of bulk drugs & ingredients need to be registered with the FDA, undergo mandatory inspections, and abide by GMP guidelines.

For instance, the FDA has stated that around 70% of registered firms have been inspected, of which 28 firms have been issued FDA Form 483s (non-adherence to cGMP regulations and unsafe compounding practices), and five warning letters, which implies a very high rate of action.

Compounding pharmacies registering with the FDA could serve to increase credibility. However, inspections and compliance with good manufacturing practices is compulsory. Regulatory pressures on compounding pharmacies are expected to force the smaller ones to close their business primarily due to unsafe compounding practices, which are likely to directly impact patient safety.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-us-978

Hormone Replacement Therapeutic Area to Hold over 38% Revenue Share in Market

By product type, oral medication is expected to dominate the U.S. compounding pharmacies market in terms of revenue, which is then followed by topical medication. The injectable segment by product type of the U.S. compounding pharmacies market is projected to grow at a significant rate as compared to other segments.

The hormone replacement therapy segment is the leading segment in terms of revenue among all the therapeutic area segments of the U.S. compounding pharmacies market, and is estimated to gain a 38.4% revenue share in 2022.

Among the pharmacy type segments, the 503A pharmacy segment is expected to gain a major revenue share as compared to the 503B pharmacy segment over the forecast period. By application, the adults segment is estimated to dominate the U.S. compounding pharmacies market, followed by the paediatrics segment. The veterinary segment is expected to grow at a faster pace as compared to the other application segments of the U.S. compounding pharmacies market.

Buy Now@ https://www.futuremarketinsights.com/checkout/978

The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy, Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Millers Pharmacy, Centene Corporation, Infinity Care Solutions, Triumph Pharmacy, and Sixth Avenue Medical Pharmacy.

Explore Other Reports Links from Healthcare Market

Cardiac Ultrasound Systems Market:- Future Market Insights (FMI) states that Cardiac Ultrasound Systems Market revenue grew by 6% between 2016 and 2020. It is predicted that sales will increase at a CAGR of 5.0%between 2021 and 2031.

Medication Management Systems Market The global market for Medication Management Systems is anticipated to grow at a CAGR of 11% between 2022 and 2032, reaching US$ 7.1 billion.

Advance Wound Care Market:- The Advance Wound Care Market is expected to witness phenomenal opportunities by exhibiting a stable CAGR of 3.7% during the forecast period between 2021 to 2031.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Neurovascular Guidewires Market Analysis and Opportunity Assessment 2022-2028

The global Neurovascular Guidewires Market is projected register CAGR of 4.0% during the forecast period 2022-2028. Increasing demand for straight tip guidewires for minimally invasive spine and cervical surgeries is accelerating the growth in the market.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-3121

The global demand for neurovascular guidewires will reach the valuation of nearly US$ 316.2 million in 2022, witnessing an estimated increase of 3.6% over 2022. Over 2022-2028, the global Neurovascular Guidewires Market revenue is likely to expand 1.5X.

According to a new research study of Future Market Insights,

  • Straight tip guidewires, with a current share of more than a third of the total market value, will retain the dominant position in neurovascular guidewires market through 2028.
  • Aneurysms and intra-and extra-cranial angioplasty reflect highest applicability of neurovascular guidewires.
  • Hospitals, though anticipated to reflect limited investment opportunities in the neurovascular guidewire market, will remain the leading end-use segment with the maximum share in terms of revenue generation.
Attribute Details
Neurovascular Guidewires Market Size Value in 2021 US$ 303.4 Mn
Neurovascular Guidewires Market Size Value in 2022 US$ 316.2 Mn
Neurovascular Guidewires Market Size Value in 2028 US$ 399.1 Mn
Neurovascular Guidewires Market Historical CAGR (2013-2021) 3.4%
Neurovascular Guidewires Market CAGR (2022-2028) 4.0%

The Increasing Number of Neurovascular Disease Treatment Alternatives

Neurovascular guidewires, among the latest innovations in the neurovascular disease treatment landscape, has been pushing the number of neurovascular surgeries since introduction. This according to the report will remain a key factor sustaining demand for neurovascular guidewires in the global market over the coming years.

As the advent of technology used in neurovascular surgeries has significantly increased the number of treatment options for neurovascular diseases, the treatment by using neurovascular guidewires is gaining ground rapidly owing to the relatively lower risk associated with surgical treatment, over conventional surgeries. The usage of guidewires is the mainstay for neurovascular therapy, along with new technologies such as coating-based guidewires, which has contributed substantially to the treatment options for complex lesions that are treated surgically.

The increasing number of neurovascular neuroradiology procedures is also boosting the demand for access products, which is another factor driving the neurovascular guidewires market. The number of neurovascular interventions is increasing with growing awareness among surgeons about the cost benefit associated with the neurovascular guidewires. Besides, reimbursement policies for outpatient surgeries are also expected to propel the neurovascular guidewires market revenue.

Furthermore, an increase in the number of end users such as ambulatory surgical centers in underdeveloped and developing countries is boosting the number of outpatients cases, which is also expected to drive the overall market for neurovascular guidewires.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3121

Scope of the Report

Attribute Details
Forecast
Period		 2022-2028
Historical Data
Available for		 2013-2021
Market
Analysis		 US$ Mn for Value
Key Regions
Covered		 North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA
Key Countries
Covered		 United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market
Segments
Covered		 Product, Application, Coating Type, End User, and Region
Key
Companies
Profiled		 • Asahi Intec Co. Ltd.

• Stryker Corporation

• Medtronic PLC

• Boston Scientific Corporation

• B. Braun Melsungen AG

• Cardinal Health Inc.

• Cook Medical Inc.

• Smiths Group PLC.

• Integra LifeSciences Corporation

• Conmed Corporation

• Others

Favorable Reimbursement Scenario & Government Support

The growing prevalence and incidence of cerebral infarction, aneurysm, and stroke is projected to fuel the demand for neurovascular guidewires. Growth in the number of patients suffering from ischemic stroke across the world is also estimated to boost the adoption of neurovascular guidewire and contribute to the growth of the global neurovascular guidewire market during the forecast period.

Similarly, increasing incidence of arteriovenous malformations is also contributing to growth in the demand for neurovascular guidewires. The increasing prevalence of intracranial and extracranial angioplasty is another factor that is expected to drive the neurovascular guidewires market.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3121

Neurovascular guidewires are effective and safe devices in neurovascular intervention procedures for patients suffering from neurovascular diseases. Modifications in reimbursement policies are encouraging the number of outpatients in developed countries. Government initiatives and local reimbursement policies pertaining to the usage of neurovascular guidewires are also expected to boost the neurovascular guidewire market over the forecast period.

Rising awareness about cerebral infarction is also estimated to contribute to the growth of the market. The reimbursement policies for the treatment of brain aneurysm are also contributing to the growth of the neurovascular guidewires market as the patients are not required to pay from their own pocket.

FMI’s report tracks some of the key companies operating in the neurovascular guidewire market, which include Boston Scientific Corporation, Medtronic, Penumbra Inc., Stryker, Asahi Intecc Co. Ltd, Integer Holding Corporation, Cordis Corporation, CONMED Corporation, phenox GmbH, and Integer Holding Corporation, among others.

Explore Other Reports Links from Healthcare Market

Metagenomics Market:- Widespread adoption of metagenomics tools in environmental monitoring and pollution reduction projects is estimated to boost the Metagenomics Market growth.

Dental Lasers Market:- Dental Lasers Market is likely to surpass a value of US$ 409 million in terms of revenue, indicating an increase of 1.4x in market growth rate, over the forecast period of 2022-2026.

Cardiac Ultrasound Systems Market:- Future Market Insights (FMI) states that Cardiac Ultrasound Systems Market revenue grew by 6% between 2016 and 2020. It is predicted that sales will increase at a CAGR of 5.0%between 2021 and 2031.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Cold Disposable Biopsy Forceps Market Growth, Regional Analysis, Trends and Forecast 2022-2031

The global demand for Cold Disposable Biopsy Forceps Market increased at 8.4% CAGR from 2021 to 2031, from an estimated market value of around US$ 542.7 Mn in 2021.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-14240

According to a recent study by Future Market Insights (FMI), the Cold Disposable Biopsy Forceps Market is expected to witness high growth during the forecast period. The market value is slated to increase from US$ 505.1 Mn in 2020 to over US$ 1,215.0 Bn by 2031 at 8.4% CAGR over the forecast period (2021-2031).

Data Points Market Insights
Cold Disposable Biopsy Forceps Market Value 2020 US$ 505.1 Mn
Cold Disposable Biopsy Forceps Market Value 2031 US$ 1,215.0 Bn
CAGR 2021-2031 8.4%
Top 5 Countries % Share 66.0%
Cold Disposable Biopsy Forceps Market Key Players Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical and others (100% Market Share)

The cold disposable biopsy forceps market will register high demand due to the rising prevalence bronchitis and gastrointestinal disorders such as IBD and GERD among the geriatric population and the increasing awareness towards endoscopic procedures. There is also a rise in the adoption of disposable biopsy forceps that to be reliable for test sampling expects to gain popularity.

At present, the minimally-invasive technology, with the endoscope system at the core, has been extended to obstetrics, general surgery, otolaryngology, gynecology, thoracic surgery, urology, pediatrics, and other departments. Minimally-invasive endoscopic technology has become an indispensable technology for the diagnosis and treatment of chronic diseases associated with breathing, digestion, urology, otolaryngology, and so on.

With the rising demand for endoscopic minimally-invasive technology and continuous improvement in endoscopic processing technology, endoscopic applications have become prominent in almost all departments. The growing demand for diagnosis and endoscopic treatment is expected to further boost the demand for cold disposable biopsy forceps.

Numerous recent technological advances are becoming available to endoscopists. An abundance of new imaging modalities is expected to facilitate early detection of chronic disorders and other pathological entities. Most of these techniques remain investigational and are currently in clinical trials to determine patient benefits.

Companies are expanding their product lines by manufacturing different types of products for a wide range of applications.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14240

Scope of the Report

Attribute Details
Forecast Period 2021-2031
Historical Data Available for 2016-2020
Market Analysis US$ Mn for Value, (‘000’ Units) for Volume
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa
Key Countries Covered US, Canada,  Brazil,  Mexico, Germany, U.K., France, Italy, Spain,  BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia and New Zealand, GCC Countries, Turkey, South Africa, and North Africa
Key Market Segments Covered Product, Diameter, Length, Application, End User, and Region
Key Companies Profiled
  • Olympus Corporation
  • Boston Scientific Corporation
  • STERIS
  • CONMED Corporation
  • Cook Medical
  • Micro-Tech Endoscopy
  • Anrei Medical

For instance, Micro-Tech Endoscopy is mainly engaged in the R&D, manufacturing, and sales of minimally-invasive medical devices, in line with its mission of supporting clinicians with technology and innovation.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14240

Key Takeaways from Cold Disposable Biopsy Forceps Market Study

  • Oval cup forceps gained popularity and their sales are expected to grow at a CAGR of 8.8% during the forecast period.
  • 2.8 mm diameter have sharpened cups which ensure superior cutting performance and lead to fewer artefacts and less bleeding. The segment is therefore expected to account for a share of 24.9% in 2021.
  • 2300 mm length forceps has precise jaws, no tearing and cause small wound. The segment accounted for the highest share of 37.9% in 2021.
  • Upper GI Endoscopy dominated the application segment with the highest market share of 24.9% in 2021.
  • Hospitals accounted for the largest share of around 42.0% in 2021 and will remain the end user in the market.

Who is winning?

The key players are focusing on acquisitions and partnerships with small players and suppliers to increase their market presence. Besides this, they are adopting various strategies to expand their footprint. For instance:

In April 2018, Boston Scientific Corporation closed its acquisition of NxThera. The company developed a minimally-invasive therapy the Rezūm system, for patients suffering from symptomatic benign prostatic hyperplasia. With the completion of the acquisition, NxThera became a part of Boston Scientific’s urology and pelvic health business. Moreover, the manufacturers are focusing on research and development activities for developing cold disposable biopsy forceps for various research applications.

In July 2020, ChargePoint and STERIS collaborated to develop a fully validated sterile transfer solution to offer a unique and integrated solution for sterile product transfer.

Some of the leading players in the cold disposable biopsy forceps market include but are not limited to Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical and other companies.

Buy Now@ https://www.futuremarketinsights.com/checkout/14240

Explore Other Reports Links from Healthcare Market

Medication Management Systems Market The global market for Medication Management Systems is anticipated to grow at a CAGR of 11% between 2022 and 2032, reaching US$ 7.1 billion.

Advance Wound Care Market:- The Advance Wound Care Market is expected to witness phenomenal opportunities by exhibiting a stable CAGR of 3.7% during the forecast period between 2021 to 2031.

Metagenomics Market:- widespread adoption of metagenomics tools in environmental monitoring and pollution reduction projects is estimated to boost the Metagenomics Market growth.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Bioimpedance Devices Market Projected to Gain Significant Value through 2022-2028

Sales in the global Bioimpedance Devices Market are slated to top US$ 492.1 Mn in 2022. Expanding at a healthy 6.4% CAGR, the market size is projected to total US$ 715.1 Mn by 2028.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-5563

Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance Devices Market throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by gradual loss of kidney function over time. As per the National Kidney Foundation, Inc., 30 million American adults have Chronic Kidney Disease and millions of others are at high risk of developing CKD.

Attribute Details
Bioimpedance Devices Market Estimated Size 2022 US$ 492.1 Mn
Bioimpedance Devices Market Value-based CAGR (2022-2028) ~6.4%
Bioimpedance Devices Market Size in Projected 2028 US$ 715.1 Mn

The Glomerular filtration rate (GFR) is the best overall index for studying kidney function. Bioelectrical impedance or Bioimpedance is used for improved estimation of glomerular filtration rate in non-diabetic patients with chronic kidney disease and also to estimate muscle mass. Bioelectrical impedance analysis (BIA) can also be used to measure appendicular lean mass (ALM).

The performance of these equations that include ALM BIA to estimate renal inulin clearance (GFR INU) can be compared with demographic variables and further used for modifications in diet for renal disease (MDRD) treatment.

Widespread online marketing channels have tremendously increased the sale of portable as well as hand-held Bioimpedance devices in recent years. For Instance, a research study estimated that in 2015, approximately 70% of the population in the U.S. depended on online shopping portals for buying different items.

Vendors operating in the Bioimpedance devices market are focusing on promotional strategies and online marketing to ensure better access to their devices and increase sales. Devices offered online also help vendors cut on operational and distribution costs.

The online marketing channel also allows vendors to offer information about devices in their portfolio and gain access to both global and local markets. In addition, these online marketing websites provide a broad selection of high-quality Bioimpedance systems at more affordable costs.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5563

Scope of the Report

Attribute Details
Forecast Period 2013-2021
Historical Data Available for 2022-2028
Market Analysis Units for Volume and US$ Mn for Value
Key Regions Covered North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa.
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market Segments Covered Product Type, Modality, End Users, and Region
Key Companies Profiled • General Electric Company

• Omron Corporation

• Fresenius Medical Care

• ImpediMed Limited

• SELVAS AI Inc.

• Tanita Corporation

• RJL Systems, Inc.

• Maltron International Ltd.

• Bodystat Limited

• SMT Medical GmbH

Majority of the manufacturers in the Bioimpedance Devices makers are focusing on developing products that are portable and affordable. The popularity of portable Bioimpedance devices is increasing due to its various advantages. For instance, Bioimpedance Devices are noninvasive, reasonable, safe and easy to operate.

These devices are light in weight and thus, are extensively used in home-based healthcare settings for monitoring health of the entire family. All these factors, cumulatively, are expected to drive the demand for portable Bioimpedance devices during the forecast period. Portable/ Hand-held Bioimpedance devices are also tremendously being opted by people for traveling purposes.

For instance, the demand for ImpediMed SFB7, which is a hand-held Bioimpedance device, is increasing as this device is easy to carry. Technological advancements to enhance the quality of Bioimpedance devices and increase patient compliance are also projected to drive the growth of the market over the forecast period.

Multiple-frequency Bioimpedance Devices are highly preferred because these devices can measure impedances in various frequencies. This provides a better and efficient estimation of fat free mass, total body water and intra and extra cellular water.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-5563

Single frequency Bioimpedance devices can calculate fat free mass and total body water but these devices are not capable of estimating intra and extra cellular body water. Increasing popularity and growing awareness about multiple-frequency Bioimpedance devices is expected to boost market growth for Bioimpedance devices over the forecast period.

FMI has segmented the global Bioimpedance Devices market by product type, modality and end user. The Bioimpedance Devices market, by product type, is segmented into Single-frequency Bioimpedance Devices and Multiple-frequency Bioimpedance Devices. By Modality, the Bioimpedance devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices.

Bioimpedance Devices, by end users, are segmented into Hospitals, Specialty Clinics, Rehabilitation Centers and Others. Region-wise segmentation includes North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. The wired Bioimpedance devices segment in the Bioimpedance Devices market is expected to witness a significant growth during the forecast period.

The report tracks some of the key companies operating in the Bioimpedance Devices market, including General Electric Company, Omron Corporation, Fresenius Medical Care, ImpediMed Limited, SELVAS AI Inc., Tanita Corporation, RJL Systems, Inc., Maltron International Ltd., Bodystat Limited and SMT Medical GmbH.

Buy Now@ https://www.futuremarketinsights.com/checkout/5563

Explore Other Reports Links from Healthcare Market

Dental Lasers Market:- Dental Lasers Market is likely to surpass a value of US$ 409 million in terms of revenue, indicating an increase of 1.4x in market growth rate, over the forecast period of 2022–2026.

Cardiac Ultrasound Systems Market:- Future Market Insights (FMI) states that Cardiac Ultrasound Systems Market revenue grew by 6% between 2016 and 2020. It is predicted that sales will increase at a CAGR of 5.0%between 2021 and 2031.

Medication Management Systems Market:- The global market for Medication Management Systems is anticipated to grow at a CAGR of 11% between 2022 and 2032, reaching US$ 7.1 billion.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Psoriatic Arthritis (PsA) Treatment Market size is projected to total US$ 15.6 Bn by 2028

Sales in the global Psoriatic Arthritis (PsA) Treatment Market are slated to top US$ 10.3 Bn in 2022. Expanding at a healthy 7.1% CAGR, the market size is projected to total US$ 15.6 Bn by 2028.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-2718

The Psoriatic Arthritis (PsA) Treatment Market is expected to register 7.1% CAGR between 2022 and 2028, up from 6.7% CAGR recorded during 2013-2021, predicts Future Market Insights.

Nearly 70% of the psoriasis patient population is prone to psoriatic arthritis, and up to 20% of arthritis patients are susceptible to acquire psoriasis, according to the recent findings of the Arthritis Foundation.

Attribute Details
Psoriatic Arthritis (PsA) Treatment Market Estimated Size
2022		 US$ 10.3
Bn
Psoriatic Arthritis (PsA) Treatment Market Value-based
CAGR (2022-2028)		 ~7.1%
Psoriatic Arthritis (PsA) Treatment Market Size in Projected
2028		 US$ 15.6
Bn

The rate of increasing burden of psoriasis and psoriatic arthritis on healthcare industry has been boosting clinical research in the field of psoriatic arthritis, in recent years.

Sustained adoption of conventional disease modifying anti-rheumatic drugs (DMARDs), especially in cost sensitive regions, is projected to push the demand for psoriatic arthritis treatment in coming years.

Role of Strong Product Pipeline & Mounting Clinical Research Investments

Over 20 drugs for psoriasis and psoriatic arthritis are currently in the phase II of pipeline, whereas more than 28 are in phase III of clinical trial, as indicated by the National Psoriasis Foundation. However, around 24 drugs have already received FDA approval for inclusion in the treatment for psoriasis and psoriatic arthritis.

While such a strong product pipeline continues to drive the demand for psoriasis and psoriatic arthritis treatment, a new research points to the shifting focus of several drug manufacturers to competitive pricing strategies, in an effort to attain widespread acceptance in coming years. Recently, Future Market Insights released a new intelligence based on the analysis of global psoriatic arthritis treatment market. The study forecasts a robust over-7% yearly growth for the market in 2022.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-2718

Scope of the Report

Attribute Details
Forecast Period 2013-2021
Historical Data
Available for		 2022-2028
Market
Analysis		 Units for Volume and US$ Bn for Value
Key Regions
Covered		 North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.
Key Countries
Covered		 United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market
Segments
Covered		 Product, Route of Administration, Distribution Channel, and Region
Key
Companies
Profiled		 • Pfizer Inc.

• Johnson & Johnson

• AbbVie Inc.

• Amgen Inc.

• Bristol-Myers Squibb Company

• UCB S.A.

• Eli Lilly & Co

• Novartis AG

• Celgene Corporation

• AstraZeneca PLC

Industry Behemoths Cover More than 55% Market Value Share

In a fairly consolidated global landscape of psoriatic arthritis treatment market, more than 55% share of the total revenue is accounted by industry giants such as Novartis AG and AbbVie Inc. that include biologics in their core portfolio. While market leaders are maintaining focus on FDA approvals and clinical trials, research also points to the increasing importance of diverse pricing strategies.

Moreover, prominent players in psoriatic arthritis treatment market are likely to augment investments in R&D of biosimilars, biologics, and TNF (tumor necrosis factor) inhibitors to target regional markets. A number of leading drug manufacturers are also maintaining sizable investments in DMARDs that are scheduled for market entry in next few years. This is perceived as a strong factor improving growth prospects of psoriatic arthritis treatment market, according to the report.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2718

Besides all these, strategic acquisitions, partnerships, and collaborations will remain the preferred expansion strategies adopted by a majority of prominent operators in psoriatic arthritis treatment landscape,” says a senior research analyst at the company.

Demand for Biologics & DMARDs Gaining Momentum

Research-driven understanding of the pathophysiology of psoriatic arthritis is fueling the introduction of innovative therapies in psoriatic arthritis treatment market, triggering innovations among the market participants – thereby supporting the growth of psoriatic arthritis treatment market. Targeted biological therapy has been demonstrating a decent success rate in terms of inducing temporary pain relief resultant of psoriatic arthritis, and thus continues to represent an attractive position in the psoriatic arthritis treatment market.

The report says that the demand for biologics accounts for more than 55% share of the global market revenue, whereas DMARDs demand makes up for more than 3/4th of the total market value. Although a majority of psoriatic arthritis patients opt for injectable as a preferred route of administration of psoriatic arthritis treatment, increasing introduction of innovative oral drugs is uplifting the popularity of orally administered psoriatic arthritis treatment.

Development of novel oral treatments for psoriatic arthritis is likely to favor the growth of North America’s market. Growing availability of combination therapies and relatively economical biosimilar antibody therapeutics are identified to be the primary boosters for the growth of Europe’s market. Collectively, North America and Europe account for over 60% share in the global value of psoriatic arthritis treatment market. The report indicates that the psoriatic arthritis market in Asia Pacific is likely to display high growth potential in the course of next few years.

Buy Now@ https://www.futuremarketinsights.com/checkout/2718

Explore Other Reports Links from Healthcare Market

Medication Management Systems Market:- The global market for Medication Management Systems is anticipated to grow at a CAGR of 11% between 2022 and 2032, reaching US$ 7.1 billion.

Advance Wound Care Market:- The Advance Wound Care Market is expected to witness phenomenal opportunities by exhibiting a stable CAGR of 3.7% during the forecast period between 2021 to 2031.

Metagenomics Market:- widespread adoption of metagenomics tools in environmental monitoring and pollution reduction projects is estimated to boost the Metagenomics Market growth.

Dental Lasers Market:- Dental Lasers Market is likely to surpass a value of US$ 409 million in terms of revenue, indicating an increase of 1.4x in market growth rate, over the forecast period of 2022-2026.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Donor Egg IVF (In-Vitro Fertilization) Market Share 2022-2028 | By First Egg Bank, MyEggBank, Ovobank

The global Donor Egg IVF (In-Vitro Fertilization) Market is estimated to be worth around US$ 2.86 Bn in 2022. With growing popularity of donor egg IVF due to its higher success rate, the overall market is projected to grow at a robust CAGR of 7.7% between 2022 and 2028, reaching nearly US$ 4.47 Bn by 2028.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-2499

Adoption of donor egg IVF treatment accounted for the approximate revenue of US$ 2 billion in 2021, which are likely to witness a healthy spike by 6.7% in 2022. Future Market Insights (FMI) recently presented a research study on the global Donor Egg IVF Market, according to which a majority of overall adoption is registered at fertility clinics and IVF centers.

Attribute Details
Donor Egg IVF (In-Vitro fertilization) Market Estimated Size in 2022 US$ 2.86 Bn
Donor Egg IVF (In-Vitro fertilization) Market Projected Size in 2028 US$ 4.47 Bn
Donor Egg IVF (In-Vitro fertilization) Market Historical CAGR (2013-2021) 6.4%  
Donor Egg IVF (In-Vitro fertilization) Market Value-Based CAGR (2022-2028) 7.7%  

A Majority of Patients Seek Donor Egg IVF Treatment at Fertility Clinics & IVF Centers

Donor egg IVF is a procedure in which technological and pharmacological manipulation is used to help and promote pregnancy, the procedure has gained significant ground globally, in recent years. Donor egg IVF has rapidly become one of the most sought after fertility treatment alternatives among the infertile population.

The study opines that fresh donor egg cycle has been preferred over frozen donor egg cycle, attributed to the associated high rates of pregnancy and successful births. Currently, nearly 70% of donor egg IVF treatment adoption is recorded at IVF centers and fertility clinics, and more than 70% of the times, the procedure is conducted by using fresh donor egg cycle.

In the fresh donor egg cycle, eggs are retrieved, following which they are fertilized immediately and directly transferred to the recipient’s womb (uterus). The birth rate and pregnancy rate by using fresh donor egg cycle are estimated to be more than 36% and 55%, respectively. On the flipside, the birth rate and pregnancy rate by using a frozen donor egg cycle are just about 24% and 39%, respectively. According to the report, enhanced pregnancy and birth rates will continue to advocate preference for fresh donor egg IVF over frozen.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-2499

Scope of the Report

Attribute Details
Historical Data Available for 2013-2021
Forecast Period 2022-2028
Market Analysis Units for Volume and US$ Mn for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa
Key Countries Covered US, Canada, Mexico, Brazil, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, ASEAN, Turkey and South Africa
Key Segments Covered Cycle Type, End Use and Region
Key Companies Profiled
  • California Cryobank
  • ConceiveAbilities
  • Center for Human Reproduction
  • Growing Generations LLC
  • Cryos International
  • Fairfax EggBank
  • The World Egg Bank
  • Global Donor Egg Bank
  • New Life Ukraine
  • First Egg Bank
  • MyEggBank
  • Ovobank
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

The Rising Burden of Infertility Pushing Scope of Egg Donor IVF Adoption

As concluded by FMI’s analysis, with an increasing number of couples postponing first pregnancy that generally leads to higher prevalence of age-related infertility issues, it is highly likely that procedures such as in-vitro fertilization (IVF) and a step ahead, donor egg IVF, will continue to witness robust demand in years to come.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2499

Research has proven that the number of women with ovaries that have untimely ceased to function has been on a considerable rise over the recent past, and thus, donor egg remains the only chance for them to conceive and lead a successful pregnancy period. The increasing infertility burden is complemented by a strong increase in the number of female egg donors, which has been cited as another important factor pushing prospects of donor egg IVF market.

Europe’s donor egg IVF market is expected to witness strong growth in forthcoming years, followed by North America, as a result of high inbound of infertile population opting for fertility treatment, across the region. Moreover, the expensive costs of donor egg IVF treatment and favorable government initiatives and reimbursements on the same are accounting for prominence of these regions in global donor egg IVF industry. The report also indicates that donor egg IVF market in Asia Pacific will demonstrate high growth potential through the coming years, as a considerably large patient pool is seeking fertility solutions.

A majority of European countries offer good service at a reasonable budget for donor egg IVF procedures and some countries, such as Brazil and Australia, reimburse 50% of the treatment cost for unsuccessful donor egg IVF procedures, or reimburse other expenses such as accommodation or out-of-pocket costs for egg donors.

Buy Now@ https://www.futuremarketinsights.com/checkout/2499

Explore Other Reports Links from Healthcare Market

Cardiac Ultrasound Systems Market:- Future Market Insights (FMI) states that Cardiac Ultrasound Systems Market revenue grew by 6% between 2016 and 2020. It is predicted that sales will increase at a CAGR of 5.0%between 2021 and 2031.

Medication Management Systems Market:- The global market for Medication Management Systems is anticipated to grow at a CAGR of 11% between 2022 and 2032, reaching US$ 7.1 billion.

Advance Wound Care Market:- The Advance Wound Care Market is expected to witness phenomenal opportunities by exhibiting a stable CAGR of 3.7% during the forecast period between 2021 to 2031.

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Hearing Aids Market | Cost Structure Analysis and Forecast to 2032 – By FMI

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

Get Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1156

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Hearing Aids market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Hearing Aids market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Hearing Aids Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Hearing Aids market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Hearing Aids market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Hearing Aids market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Discounted prices for new customers! Offer expires soon!

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1156

Hearing Aids Market: Segmentation

Valuable information covered in the FMI’s Hearing Aids market report has been segregated into key segments and sub-segments.

By Product Type:

  • Receiver
  • Behind the Ear
  • In the Canal
  • In the Ear Aids

By Implants:

  • Cochlear
  • Bone-anchored

By Type of Hearing Loss:

  • Sensorineural
  • Conductive

By Patient Type:

  • Adults
  • Paediatrics

Hearing Aids Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Hearing Aids market. Competitive information detailed in the Hearing Aids market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Hearing Aids market report.

Key players covered in the report include:

  • ReSound
  • Widex
  • Oticon
  • Siemens AG
  • Starkey Hearing Technologies Inc.
  • Phonak Hearing Systems
  • Audina Hearing Instrument Inc.
  • Cochlear Ltd
  • Amplifon SpA
  • GN Hearing AS

Important Questions Answered in the Hearing Aids Market Report

  • Which end user remains the top revenue contributor in different regional markets?
  • At what rate has the global Hearing Aids market been expanding during the forecast period?
  • How will the global Hearing Aids market look like by the end of the forecast period?
  • What innovative strategies are adopted by Hearing Aids market players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Hearing Aids market?

Buy Now@ https://www.futuremarketinsights.com/checkout/1156

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
  • Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
  • Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Hearing Aids market

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs